We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$12.4B
AUM Growth
+$271M
(+2.2%)
Cap. Flow
-$478M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
289
New
32
Increased
64
Reduced
138
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$127M |
| 2 |
Gilead Sciences
GILD
|
+$125M |
| 3 |
PayPal
PYPL
|
+$89.3M |
| 4 |
UnitedHealth
UNH
|
+$88.1M |
| 5 |
GE Aerospace
GE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$148M |
| 2 |
Kroger
KR
|
+$105M |
| 3 |
Costco
COST
|
+$94.8M |
| 4 |
Lam Research
LRCX
|
+$79.3M |
| 5 |
Charter Communications
CHTR
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Technology | 16.23% |
| 3 | Industrials | 15.74% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.78T
| $278M | 2.24% |
9,829,640
-1,775,740
| -15% | -$47M |
|
2
Microsoft
MSFT
$2.87T
| $260M | 2.1% |
4,511,997
-266,681
| -6% | -$15.1M |
|
3
Meta Platforms (Facebook)
META
$1.54T
| $222M | 1.79% |
1,727,766
+86,998
| +5% | +$10.8M |
|
4
Jazz Pharmaceuticals
JAZZ
$16B
| $199M | 1.61% |
1,637,937
-146,825
| -8% | -$19.8M |
|
5
Visa
V
$671B
| $196M | 1.58% |
2,364,295
+251,998
| +12% | +$20.2M |
|
6
Constellation Brands
STZ
$22.2B
| $195M | 1.57% |
1,171,058
-64,219
| -5% | -$10.6M |
|
7
Amazon
AMZN
$2.52T
| $193M | 1.56% |
4,604,920
+1,010,540
| +28% | +$38.7M |
|
8
Steris
STE
$20.7B
| $189M | 1.53% |
2,591,499
-443,702
| -15% | -$31.3M |
|
9
Newell Brands
NWL
$2.15B
| $181M | 1.46% |
3,432,925
-49,144
| -1% | -$2.54M |
|
10
Alphabet (Google) Class A
GOOGL
$3.92T
| $180M | 1.46% |
4,487,720
-263,720
| -6% | -$10.3M |
|
|
11
Alphabet (Google) Class C
GOOG
$3.92T
| $175M | 1.41% |
4,500,700
-262,780
| -6% | -$9.98M |
|
12
Palo Alto Networks
PANW
$267B
| $174M | 1.41% |
6,567,354
+166,524
| +3% | +$3.79M |
|
|
13
Charter Communications
CHTR
$15B
| $171M | 1.38% |
633,894
-289,930
| -31% | -$73.2M |
|
14
United Airlines
UAL
$38B
| $164M | 1.32% |
3,122,371
-190,677
| -6% | -$9.17M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $162M | 1.3% |
1,545,221
-75,652
| -5% | -$8.19M |
|
16
ServiceNow
NOW
$100B
| $155M | 1.25% |
9,793,560
+1,493,805
| +18% | +$22M |
|
17
Bristol-Myers Squibb
BMY
$126B
| $138M | 1.11% |
2,557,862
-161,685
| -6% | -$10.4M |
|
18
Mettler-Toledo International
MTD
$26.7B
| $133M | 1.07% |
316,978
+81,500
| +35% | +$32.4M |
|
|
19
Abbott
ABT
$177B
| $126M | 1.01% |
+2,973,638
| New | +$127M |
|
|
NLSN
20
DELISTED
Nielsen Holdings plc
NLSN
| $123M | 0.99% |
2,298,874
-140,071
| -6% | -$7.45M |
|
21
Salesforce
CRM
$133B
| $123M | 0.99% |
1,720,650
-20,101
| -1% | -$1.57M |
|
22
Cooper Companies
COO
$13.7B
| $122M | 0.99% |
2,729,648
-411,804
| -13% | -$18.8M |
|
23
Union Pacific
UNP
$180B
| $121M | 0.98% |
1,244,775
-198,085
| -14% | -$18.5M |
|
|
24
Gilead Sciences
GILD
$162B
| $121M | 0.98% |
+1,532,818
| New | +$125M |
|
25
DuPont de Nemours
DD
$18.6B
| $121M | 0.98% |
923,132
-309,626
| -25% | -$41.3M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Westfield Capital Management held 289 positions worth $12.4B, up 2.2% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $478M in Q3 2016, closing 40 positions and reducing 138 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
Against the trend, Westfield Capital Management opened a new position in Abbott worth $126M.
- Westfield Capital Management's largest Q3 2016 buy was Abbott: 2,973,638 shares worth $126M.
- Westfield Capital Management added most to UnitedHealth in Q3 2016, an estimated $88.1M increase.
- Westfield Capital Management's biggest Q3 2016 reduction was Costco, cutting an estimated $94.8M.
- Westfield Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $148M.
- Westfield Capital Management's ten largest holdings make up 17% of its $12.4B portfolio in Q3 2016.
- Westfield Capital Management opened 32 new positions and closed 40 in Q3 2016.
- Westfield Capital Management's portfolio value rose 2.2% quarter-over-quarter to $12.4B.
Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.